Stock Analysis
- China
- /
- Medical Equipment
- /
- SZSE:300396
Three Insider-Favored Growth Companies To Watch
Reviewed by Simply Wall St
In a week marked by mixed performances across global markets, the Nasdaq Composite stood out by hitting a record high, driven largely by growth stocks outperforming their value counterparts. As investors navigate this landscape of economic adjustments and anticipated interest rate changes, companies with strong insider ownership can offer unique insights into potential growth opportunities. In this context, identifying stocks favored by insiders may provide an edge in understanding where these stakeholders see long-term value amidst fluctuating market conditions.
Top 10 Growth Companies With High Insider Ownership
Name | Insider Ownership | Earnings Growth |
Seojin SystemLtd (KOSDAQ:A178320) | 30.9% | 39.9% |
SKS Technologies Group (ASX:SKS) | 27% | 24.8% |
Laopu Gold (SEHK:6181) | 36.4% | 34.2% |
Medley (TSE:4480) | 34% | 31.7% |
Plenti Group (ASX:PLT) | 12.8% | 120.1% |
Brightstar Resources (ASX:BTR) | 16.2% | 84.5% |
Fine M-TecLTD (KOSDAQ:A441270) | 17.2% | 131.1% |
Fulin Precision (SZSE:300432) | 13.6% | 66.7% |
HANA Micron (KOSDAQ:A067310) | 18.5% | 110.9% |
Findi (ASX:FND) | 34.8% | 112.9% |
Let's take a closer look at a couple of our picks from the screened companies.
Genomictree (KOSDAQ:A228760)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Genomictree Inc. is a biomarker-based molecular diagnostics company that develops and commercializes products for detecting cancer and infectious diseases, with a market cap of ₩563.77 billion.
Operations: The company's revenue segments consist of ₩2.06 billion from the Cancer Molecular Diagnosis Business and ₩144 million from Genomic Analysis and Other Business.
Insider Ownership: 16.1%
Revenue Growth Forecast: 97.8% p.a.
Genomictree exhibits a compelling growth trajectory, with revenue forecasted to grow at 97.8% annually, significantly outpacing the Korean market's 5.2% growth rate. Despite lacking meaningful current revenue (₩2B) and having a low projected Return on Equity of 5.7%, it is expected to become profitable within three years, surpassing average market profit growth. The stock trades at 62.6% below its estimated fair value but has experienced high volatility recently.
- Click here and access our complete growth analysis report to understand the dynamics of Genomictree.
- Our comprehensive valuation report raises the possibility that Genomictree is priced higher than what may be justified by its financials.
Dirui IndustrialLtd (SZSE:300396)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Dirui Industrial Co., Ltd. focuses on the research, development, production, and sale of medical inspection products in China and has a market capitalization of approximately CN¥4.76 billion.
Operations: The company generates revenue primarily from its Medical Instruments segment, amounting to CN¥1.50 billion.
Insider Ownership: 12.2%
Revenue Growth Forecast: 35.4% p.a.
Dirui Industrial Ltd. is poised for significant growth, with earnings expected to rise 40.54% annually, outpacing the Chinese market's 25.7%. Despite a low forecasted Return on Equity of 13.4%, its Price-To-Earnings ratio of 20.3x suggests good value compared to the market average of 36.2x. Recent earnings show sales increased to CNY1.18 billion, though net income declined, highlighting potential volatility in its growth trajectory amidst high insider ownership dynamics.
- Unlock comprehensive insights into our analysis of Dirui IndustrialLtd stock in this growth report.
- According our valuation report, there's an indication that Dirui IndustrialLtd's share price might be on the cheaper side.
Japan Elevator Service HoldingsLtd (TSE:6544)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Japan Elevator Service Holdings Co., Ltd. specializes in providing repair, maintenance, and modernization services for elevators and escalators in Japan, with a market cap of ¥252.21 billion.
Operations: Revenue Segments (in millions of ¥): Repair and maintenance services: ¥17,500; Modernization services: ¥6,200.
Insider Ownership: 22.1%
Revenue Growth Forecast: 11.9% p.a.
Japan Elevator Service Holdings Ltd. is experiencing robust growth, with earnings increasing by 38.7% over the past year and forecasted to grow 19% annually, outpacing Japan's market average of 7.9%. The company's revenue is expected to grow at 11.9% per year, higher than the market's 4.2%. Recent executive changes and a new service office in Chiba indicate strategic expansion efforts, while analysts anticipate a potential stock price increase of 30.6%.
- Get an in-depth perspective on Japan Elevator Service HoldingsLtd's performance by reading our analyst estimates report here.
- The analysis detailed in our Japan Elevator Service HoldingsLtd valuation report hints at an inflated share price compared to its estimated value.
Summing It All Up
- Access the full spectrum of 1567 Fast Growing Companies With High Insider Ownership by clicking on this link.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Looking For Alternative Opportunities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About SZSE:300396
Dirui IndustrialLtd
Engages in the research and development, production, and sale of medical inspection products in the People's Republic of China.